Diseases, Conditions, Syndromes

Uncovering the relationship between fatty liver disease and COVID-19

Dr. Jawaher Alharthi, from the Westmead Institute and medical research, University of Sydney, Australia, and her colleagues have discovered how COVID-19 increases the risk of fatty liver disease and how the latter is increasing ...

Diseases, Conditions, Syndromes

Movement toward a poop test for liver cirrhosis

For the estimated 100 million U.S. adults and children living with nonalcoholic fatty liver disease (NAFLD), whether or not they have liver cirrhosis, or scarring, is an important predictor for survival. Yet it's difficult ...

Diseases, Conditions, Syndromes

Common acid reflux medications promote chronic liver disease

Approximately 10 percent of the general population take a proton pump inhibitor (PPI) drug to block stomach acid secretions and relieve symptoms of frequent heartburn, acid reflux and gastroesophageal reflux disease. That ...

Diseases, Conditions, Syndromes

Fatty liver can cause damage to other organs via crosstalk

Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

page 2 from 34